Incidence and clinical relevance of heparin-induced antibodies in critically ill patients

por Grigoriou, P, Grouzi, E, Evagelopoulou, P, Haikali, A, Spiliotopoulou, I, Baltopoulos, G
Publicado 2004

Monocyte normal immune response to LPS stimulation

por Myrianthefs, P, Venetsanou, K, Grouzi, E, Boutzouka, E, Evagelopoulou, P, Fildissis, G, Spiliotopoulou, I, Baltopoulos, G
Publicado 2002

Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature

por Papadakis, E., Pouliakis, A., Aktypi, Α., Christoforidou, A., Kotsi, P., Αnagnostou, G., Foifa, A., Grouzi, E.
Publicado 2019

Impact of critical illness severity on transfusion requirements

por Evagelopoulou, P, Grouzi, E, Tsigou, E, Katsaros, A, Mistakeli, C, Petsimeri, V, Zidianakis, V, Spiliotopoulou, I, Baltopoulos, G
Publicado 2006

P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID-19: RESULTS OF A MULTICENTER PHASE II TRIAL

por Thomopoulos, T., Bouchla, A., Antoniadou, A., Terpos, E., Politou, M., Stamoulis, K., Koromboki, E., Papageorgiou, S., Kotanidou, A., Kalomenidis, I., Jahaj, E., Grigoropoulou, S., Pagoni, M., Grouzi, E., Poulakou, G., Trontzas, I., Labropoulou, S., Mentis, A., Bamias, A., Tsiodras, S., Dimopoulos, M.-A., Pappa, V.
Publicado 2022